The FDA has approved Otarmeni, the first-ever gene therapy for genetic hearing loss caused by the OTOF gene, for both ...
Kelly Anne is a deputy editor at Forbes Advisor overseeing the development of various initiatives, including newsletters, social media, and new content verticals. Previously, she worked as a senior ...
Otarmeni, now cleared to treat a rare, inherited kind of hearing loss, is the first gene therapy cleared under the FDA’s ...
IFLScience on MSN
First-of-its-kind gene therapy for inherited hearing loss approved by FDA as trial shows improvement in 80 percent of patients
The US Food and Drug Administration (FDA) has just approved the first-ever gene therapy for a form of inherited hearing loss.
By Sriparna Roy April 23 (Reuters) - The U.S. Food and Drug Administration has approved Regeneron's gene therapy for a rare ...
You might like the sound of this news. In a landmark move, the Food and Drug Administration on Thursday approved the first ...
The US Food and Drug Administration on Thursday approved the first gene therapy for inherited hearing loss, a one-time ...
Your brain needs sound to stay sharp. Without it, cognitive function begins to slip—often in ways you won't notice until the damage is done.
The FDA has granted an accelerated approval for Otarmeni (lunsotogene parvec-cwha), the first gene therapy to treat patients ...
First FDA-approved gene therapy for hearing loss targets a rare inherited form of deafness Treatment restored hearing in most ...
FDA approves Otarmeni gene therapy for genetic hearing loss; Regeneron offers free treatment, restoring hearing by correcting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results